Juan-ramon R. Larrubia

Donante De Sangre St
Guadalajara, CM 19002, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.

Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 10, 2026

HBsAg level defines different clinical phenotypes of HBeAg(-) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality.

HBsAg level defines different clinical phenotypes of HBeAg(-) chronic HBV infection related to HBV polymerase-specific CD8+ cell response quality.

Journal: Frontiers in immunology

Published: December 11, 2023

IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection.

IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection.

Journal: iScience

Published: May 11, 2023

Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort-authors' reply.

Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort-authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: September 28, 2022

Model to predict on-treatment restoration of functional HBV-specific CD8+ cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B.

Model to predict on-treatment restoration of functional HBV-specific CD8+ cell response foresees off-treatment HBV control in eAg-negative chronic hepatitis B.

Journal: Alimentary pharmacology & therapeutics

Published: September 12, 2021

Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma.

Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma.

Journal: Cancers

Published: March 01, 2021

Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C.

Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis C.

Journal: Cells

Published: February 03, 2021

Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history.

Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history.

Journal: World journal of hepatology

Published: June 13, 2020

Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?

Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?

Journal: World journal of gastroenterology

Published: April 01, 2018

According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity.

According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity.

Journal: Journal of virology

Published: August 28, 2017

Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.

Journal: World journal of gastroenterology

Published: March 23, 2016

Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Journal: World journal of gastroenterology

Published: November 19, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026